Trial intelligence / Profile preview

Efficacy of midazolam on blood pressure control

IRCT20181010041299N1Phase 2Completed

Sponsor
Shahroud University of Medical Sciences
Start
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of midazolam in hypertension (HTN), sponsored by Shahroud University of Medical Sciences. Started Dec 2018; status: completed.

02

Drugs

midazolam
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on IRCT20181010041299N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20181010041299N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call